Helicos Sells Sequencer to Undisclosed Biotech Firm
August 04, 2009
Helicos Sells Sequencer to Undisclosed Biotech Firm
To date, Helicos has announced instrument placements or orders at Stanford University, the Broad Institute, the Dana-Farber Cancer Institute, and the University of Maryland. The new order would be the first that it has disclosed for a commercial entity.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Latest Sequencer Placement Boosts Helicos Shares
August 20, 2009 / GenomeWeb Daily News - Mass General to Use Helicos Sequencer for Cancer Research
August 18, 2009 / In Sequence - Setting Sights on BRCA Testing Market, Helicos Develops Isolation-Free BRCA1 Sequencing Method
August 9, 2011 / Clinical Sequencing News - USPTO Grants PacBio's Reexamination Request of Four Helicos Patents; Helicos Files Response for First Patent
May 10, 2011 / In Sequence - PacBio Says It Will 'Vigorously' Defend Against Helicos' Patent Infringement Claims
September 7, 2010 / In Sequence